X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2977) 2977
Publication (153) 153
Book Chapter (71) 71
Book Review (49) 49
Conference Proceeding (4) 4
Web Resource (3) 3
Book / eBook (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
heparin-induced thrombocytopenia (2620) 2620
humans (1953) 1953
thrombocytopenia - chemically induced (1005) 1005
index medicus (992) 992
heparin - adverse effects (984) 984
hematology (936) 936
female (801) 801
male (780) 780
thrombosis (706) 706
anticoagulants - adverse effects (650) 650
peripheral vascular disease (586) 586
middle aged (583) 583
heparin (580) 580
aged (562) 562
thrombocytopenia (555) 555
anticoagulants - therapeutic use (471) 471
anticoagulants (411) 411
antibodies (408) 408
molecular-weight heparin (405) 405
adult (364) 364
argatroban (347) 347
diagnosis (346) 346
anticoagulation (344) 344
thrombocytopenia - diagnosis (305) 305
unfractionated heparin (303) 303
cardiopulmonary bypass (294) 294
surgery (279) 279
cardiac & cardiovascular systems (259) 259
thrombocytopenia - drug therapy (257) 257
risk factors (234) 234
platelet count (233) 233
management (232) 232
heparin‐induced thrombocytopenia (225) 225
hit (225) 225
anticoagulants - administration & dosage (219) 219
platelet factor 4 - immunology (217) 217
thrombocytopenia - immunology (215) 215
pharmacology & pharmacy (212) 212
heparin - immunology (210) 210
heparin - therapeutic use (203) 203
therapy (202) 202
animals (197) 197
treatment outcome (192) 192
aged, 80 and over (188) 188
fondaparinux (183) 183
venous thromboembolism (180) 180
recombinant hirudin (179) 179
platelets (177) 177
lepirudin (174) 174
thrombocytopenia - blood (168) 168
anesthesiology (163) 163
recombinant proteins - therapeutic use (160) 160
risk (160) 160
medicine & public health (158) 158
bivalirudin (155) 155
retrospective studies (153) 153
medicine, general & internal (151) 151
pipecolic acids - therapeutic use (150) 150
heparin induced thrombocytopenia (149) 149
platelet activation (144) 144
deep-vein thrombosis (141) 141
respiratory system (140) 140
glycosaminoglycans (134) 134
thrombocytopenia - complications (134) 134
enzyme-linked immunosorbent assay (131) 131
abridged index medicus (130) 130
critical care medicine (130) 130
thrombocytopenia - therapy (129) 129
thrombin (127) 127
thromboembolism (126) 126
prevention (123) 123
hirudin (115) 115
thrombosis - etiology (115) 115
hemodialysis (112) 112
direct thrombin inhibitors (111) 111
thrombocytopenia - etiology (109) 109
care and treatment (108) 108
platelet factor 4 (108) 108
partial thromboplastin time (105) 105
time factors (105) 105
thrombosis - drug therapy (104) 104
warfarin (104) 104
thrombin - antagonists & inhibitors (103) 103
analysis (101) 101
danaparoid (99) 99
fibrinolytic agents - therapeutic use (98) 98
patient (98) 98
prospective studies (98) 98
acute myocardial-infarction (97) 97
percutaneous coronary intervention (97) 97
health aspects (95) 95
thrombosis - prevention & control (94) 94
antibodies - blood (93) 93
blood coagulation - drug effects (93) 93
disseminated intravascular coagulation (93) 93
heparin - administration & dosage (93) 93
pregnancy (93) 93
dose-response relationship, drug (92) 92
pipecolic acids - administration & dosage (91) 91
complications (90) 90
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2631) 2631
German (155) 155
French (88) 88
Japanese (77) 77
Spanish (29) 29
Polish (12) 12
Chinese (10) 10
Czech (8) 8
Italian (7) 7
Russian (7) 7
Turkish (7) 7
Korean (6) 6
Lithuanian (2) 2
Dutch (1) 1
Hungarian (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Primary Care - Clinics in Office Practice, ISSN 0095-4543, 12/2016, Volume 43, Issue 4, pp. 543 - 557
Journal Article
BLOOD, ISSN 0006-4971, 05/2017, Volume 129, Issue 21, pp. 2864 - 2872
Heparin-induced thrombocytopenia (HIT) is an immune complication of heparin therapy caused by antibodies to complexes of platelet factor 4 (PF4) and heparin.... 
FACTOR 4/HEPARIN ANTIBODIES | ORTHOPEDIC-SURGERY | MOLECULAR-WEIGHT HEPARIN | PLATELET-AGGREGATION TEST | FC-GAMMA-RIIA | HEMATOLOGY | CARDIOPULMONARY BYPASS-SURGERY | TISSUE FACTOR EXPRESSION | 4TS SCORING SYSTEM | UNFRACTIONATED HEPARIN | THROMBOEMBOLIC COMPLICATIONS
Journal Article
Journal Article
Journal of Thrombosis and Haemostasis, ISSN 1538-7933, 11/2017, Volume 15, Issue 11, pp. 2099 - 2114
Summary Autoimmune heparin‐induced thrombocytopenia (aHIT) indicates the presence in patients of anti‐platelet factor 4 (PF4)–polyanion antibodies that are... 
platelet factor 4 (PF4) | autoimmunity | platelet‐activating antibodies | heparin‐induced thrombocytopenia | high‐dose intravenous immunoglobulin | high-dose intravenous immunoglobulin | heparin-induced thrombocytopenia | platelet-activating antibodies | FACTOR 4/HEPARIN ANTIBODIES | FONDAPARINUX | WARFARIN THROMBOPROPHYLAXIS | IN-VITRO | CONFORMATIONAL-CHANGES | ORTHOPEDIC-SURGERY | CARDIAC-SURGERY | CROSS-REACTIVITY | PERIPHERAL VASCULAR DISEASE | PLATELET ACTIVATION | HEMATOLOGY | platelet factor4 (PF4) | CLINICAL-PRACTICE | Blood Platelets - immunology | Anticoagulants - administration & dosage | Administration, Oral | Autoantibodies - blood | Humans | Immunologic Factors - administration & dosage | Platelet Factor 4 - immunology | Immunoglobulins, Intravenous - administration & dosage | Anticoagulants - adverse effects | Heparin - adverse effects | Purpura, Thrombocytopenic, Idiopathic - blood | Purpura, Thrombocytopenic, Idiopathic - drug therapy | Heparin - immunology | Animals | Anticoagulants - immunology | Blood Coagulation - drug effects | Blood Platelets - metabolism | Partial Thromboplastin Time | Purpura, Thrombocytopenic, Idiopathic - immunology | Purpura, Thrombocytopenic, Idiopathic - chemically induced | Platelet Activation - drug effects | Blood Platelets - drug effects | Autoimmunity - drug effects | Thrombocytopenia | Autoimmunity | Fibrin | Medical examination | Immunoglobulin G | Anticoagulants (Medicine) | Sulfates | Blood | Anticoagulants | Immunoglobulins | Intravenous administration | Immune response | Disseminated intravascular coagulation | Polyphosphates | Catheters | Immunosuppressive agents | Recruitment | Thromboplastin | Platelet factor 4 | Polyanions | Side effects | Fibrinogen | Chondroitin sulfate | Heparin | Sulfate | Platelets | Antigen-antibody complexes
Journal Article
Chest, ISSN 0012-3692, 06/2008, Volume 133, Issue 6, pp. 340S - 380S
Journal Article
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program, ISSN 1520-4391, 2012, Volume 2012, pp. 191 - 197
Journal Article